Five mongrel dogs were sensitized to tuberculoprotein with Freund adjuvant, as determined by responses to tuberculin skin tests and by in vitro lymphocyte cultures. These animals served as blood donors for production of transfer factor. Nine mongrel dogs received single doses of transfer factor that was tuberculin specific. Successful transfer of tuberculin sensitivity as measured by lymphocyte transfornations was achieved in five of nine animals. Canine lymphocyte cultures frequently showed relatively low transformations to mitogens as compared with responses noted in other animals. Dissociation between skin test reactivity and in vitro lymphocyte transformation to tuberculoprotein was noted in two of nine animals. Increases in lymphocyte transformations to phytohemagglutinin were seen in three of nine recipient animals after transfer factor administration. Successful transfer from an animal sensitized by prior transfer factor administration was achieved in one instance. These data indicate that transfer factor-like substances are present in dogs. The reasons why successful transfer was achieved in only half of the recipient animals needs further explanation. Leukocyte extracts, as described by Jeter et al. (4) , can transmit delayed hypersensitivity from sensitized guinea pigs to unresponsive animal recipients. Lawrence (6) transferred antigen-specific, cell-mediated immunity of the delayed type from sensitive humans to unresponsive human recipients. Dialysates of these leukocyte extracts have been termed transfer factor. Other transfer factor-like substances are being discovered in an increasing number of experimental animals. Dogs have become an important laboratory animal, especially in the setting of experimental transplantation surgery. This study was undertaken to confirm the presence of transfer factor-like substances in dogs. Two reports have described the existence of canine transfer factor. One study used coccidioidomycosis antigen as the primary immunological marker to prove successful transfer from one animal to another (11) . Tuberculin A through I ( Table 2) . Conversion of MT skin tests (24 mm at 72 h) was noted after transfer factor administration in four animals (recipients A, B, C, and H). Two of these four animals (recipients C and H) also had positive responses in lymphocyte transformations to PPD after transfer factor administration (from donors 2 and 5). A total of five animals developed positive stimulation indexes in response to PPD (recipients C, D, G, H, and I), three of which had negative skin tests (recipients D, G, and I). An additional finding was that an increased PHA responsiveness occurred in three of the recipient animals (recipients D, G, and H) after transfer factor administrations. Dog donors 3 Another difficulty has been in eliciting a delayed hypersensitivity response to tuberculin in the skin of dogs. The high dose (2,500 U) of MT used in the skin tests of this study has been found to be the dose most likely to elicit positive reactions in dogs infected with mycobacteria (9) .
Administration of an antigen without Freund adjuvant can cause specific, delayed hypersensitivity to that injected substance (10) . Intradermal injection of antigen has been shown to be the most effective route of immunization for eliciting a delayed hypersensitivity response (7). Consequently, it was not surprising that donor 5 became sensitized to tuberculin after intradermal injections of 2,500 U of MT at four weekly intervals. Sensitization was indicated by positive lymphocyte transformations to PPD and a positive MT skin test 1 week later.
As was found in our study, Shifrine et al. have also noted increased PHA responsiveness in dogs after administration of canine transfer factor. Successful transfer of tuberculin reactivity was accomplished in five out of nine attempts, using dialyzable transfer factor as determined by positive lymphocyte culture stimulation indexes. Two of the recipient animals had definitely negative MT skin tests that became unequivocally positive. Animals with initial skin tests that were marginally positive may have been sensitized with naturally occurring mycobacteria in soil or water. The dissociation between positive skin tests and negative blast transformation noted in our study has been previously observed in humans with chronic mucocutaneous candidiasis (5) .
The in vitro and in vivo reactivities to tuberculin found after transfer factor administration was unlike that seen after sensitization with Freund adjuvant and repeated skin testing. In the former case, the positive skin test preceded the finding of lymphocyte reactivity, whereas in the latter case, positive lymphocyte transformation preceded, or was cotemporal with, the finding of positive skin tests. It is very unlikely that skin testing the recipient animals was alone responsible for this sensitization, because different temporal patterns in onset of positive tests were noted, and also because the interval between transfer factor administration and the finding of tuberculin sensitivity was shorter. Although the onset of action of transfer factor has been noted to be as rapid as 1 day (3, 6), David (3) has noted greater reactivity at 6 days, and Lawrence (6) noted initial evidence of transfer of cutaneous reactivity as late as 30 days after administration of transfer factor. These findings in the human system are consistent with our observations in dogs.
